S. 1973 (119th)Bill Overview

Treat and Reduce Obesity Act of 2025

Health|Health
Cosponsors
Support
Lean Democratic
Introduced
Jun 5, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Finance.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill amends Medicare statutes to broaden which providers may furnish and be paid for intensive behavioral therapy (IBT) for obesity, permits certain obesity and weight-loss drugs to be covered under Medicare Part D, and requires periodic HHS reports to Congress on implementation. Non-physician providers and evidence-based community programs may provide IBT when referred by and coordinated with a physician or primary care practitioner.

Why people may split

Costs versus access: liberals emphasize access, conservatives stress spending

Watch point

Relative to its intended legislative type, this bill is a clearly focused substantive policy change that amends specific provisions of the Social Security Act to broaden provider eligibility for intensive behavioral therapy for obesity and to allow Part D coverage of obesity/weight-loss medications, and it adds a required HHS reporting cycle.

The bill amends Medicare statutes to broaden which providers may furnish and be paid for intensive behavioral therapy (IBT) for obesity, permits certain obesity and weight-loss drugs to be covered under Medicare Part D, and requires periodic HHS reports to Congress on implementation.

Non-physician providers and evidence-based community programs may provide IBT when referred by and coordinated with a physician or primary care practitioner.

Part D coverage for obesity medications would take effect for plan years beginning two years after enactment.

Passage50/100

Technocratic Medicare expansion with bipartisan potential but uncertain fiscal impact and need for negotiations on cost and implementation.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a clearly focused substantive policy change that amends specific provisions of the Social Security Act to broaden provider eligibility for intensive behavioral therapy for obesity and to allow Part D coverage of obesity/weight-loss medications, and it adds a required HHS reporting cycle.

Contention55/100

Costs versus access: liberals emphasize access, conservatives stress spending

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitIncreases beneficiary access to behavioral obesity treatment through expanded eligible provider types.
  • Potential benefitAllows coverage of anti-obesity medications under Part D, potentially lowering beneficiaries' out-of-pocket costs.
  • Potential benefitPromotes multidisciplinary care by requiring treating providers to coordinate and communicate with referring clinicians.
Likely burdened
  • Potential burdenMay increase short-term Medicare and Part D spending from higher utilization of therapies and drugs.
  • Federal agenciesExpanded drug coverage could raise Part D premiums or federal spending depending on uptake and prices.
  • Potential burdenReferral and coordination requirements add administrative workload for clinicians and program administrators.
03 · Why people split

Why the argument around this bill splits.

Costs versus access: liberals emphasize access, conservatives stress spending
Progressive90%

Likely broadly supportive because the bill expands access to obesity treatment and recognizes allied health professionals and community programs.

It aligns with priorities to cover evidence-based care for chronic disease, though advocates may push for stronger affordability safeguards and equity measures.

Leans supportive
Centrist75%

Generally favorable but cautious; welcomes increased access and use of allied providers while wanting clear cost controls and implementation oversight.

Support will depend on projected budget impacts and measurable outcomes demonstrating cost-effectiveness.

Leans supportive
Conservative45%

Mixed to skeptical: appreciates more treatment options and private-sector community programs, but worries about increased federal spending, expanded government coverage mandates, and potential medical practice interference.

Support hinges on strong cost controls and limits to federal liabilities.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood50/100

Technocratic Medicare expansion with bipartisan potential but uncertain fiscal impact and need for negotiations on cost and implementation.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • No CBO or score included to show projected costs
  • Magnitude of Part D drug cost impact unclear
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Costs versus access: liberals emphasize access, conservatives stress spending

Technocratic Medicare expansion with bipartisan potential but uncertain fiscal impact and need for negotiations on cost and implementation.

Unlocked analysis

Relative to its intended legislative type, this bill is a clearly focused substantive policy change that amends specific provisions of the Social Security Act to broaden provider eligibility for intensive behavioral the…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis